ROCKVILLE, MD -- (MARKET WIRE) -- October 16, 2006 -- Human neural stem cells (hNSCs) developed by Neuralstem, Inc. significantly extended the life of rats with a genetic mutation that gives them a disease analogous to amyotrophic lateral sclerosis (ALS) and delayed disease onset, a paper published in this issue of the journal Transplantation (http://www.transplantjournal.com) reported. The transplanted stem cells, derived from human fetal spinal cord tissue, survived well in the neurodegenerative spinal cord environment, integrated with host cells and delivered neuroprotective factors to the diseased motor neurons.
